Background: Exhaled breath condensate (EBC) is proving to be a technique which can sample markers of lung inflammation; however, many factors affect the collection process. Objectives: We hypothesised that lung volumes – tidal volume, minute volume and total lung capacity (TLC) – would dictate the volume of the EBC sample that could be collected. Methods: First, the volume of EBC collected was measured while measuring the tidal volume and minute volume in normal, asthmatic and chronic obstructive pulmonary disease subjects. Second, the volume of EBC was compared between breathing at tidal volumes and breathing at vital capacity in normal subjects. TLC was measured by plethysmography. Results: The mean EBC volume was 5.55 ± 0.50 µl/breath in normal subjects (n = 23), 3.56 ± 0.33 µl/breath in chronic obstructive pulmonary disease patients (n = 25) and 5.77 ± 0.50 µl/breath in asthmatic subjects (n = 17). EBC volume was significantly correlated with both tidal volume (Pearson’s r = 0.775, p < 0.0005) and minute volume (Pearson’s r = 0.425, p < 0.0005), but importantly, EBC volume was not significantly affected by age, gender or disease status. There was a significant difference in EBC volume when tidal breathing was compared with breathing at vital capacity (5.55 ± 0.50 vs. 20.59 ± 1.72 µl; p < 0.0001). No significant correlation was found between EBC volume and TLC (21 normal subjects). Conclusions: These results suggest that tidal and minute volume can predict the amount of EBC that can be expected to be collected. No significant differences in the volume of EBC were seen between normal subjects and those with airway diseases.

Keywords:
Exhaled breath condensate, Total lung capacity, Tidal volume, Minute volume, Water vapour
1.
Kharitonov SA, Barnes PJ: Exhaled markers of pulmonary disease. Am J Respir Crit Care Med 2001;163:1693–1722.
2.
Antczak A, Gorski P: Markers of pulmonary diseases in exhaled breath condensate. Int J Occup Med Environ Health 2002;15:317–323.
3.
McCafferty JB, Bradshaw TA, Tate S, Greening AP, Innes JA: Effects of breathing pattern and inspired air conditions on breath condensate volume, pH, nitrite, and protein concentrations. Thorax 2004;59:694–698.
4.
Baraldi E, Ghiro L, Piovan V: Safety and success of exhaled breath condensate collection in asthma. Arch Dis Child 2003;88:358–360.
5.
Antczak A, Kharitonov SA, Montuschi P, Gorski P, Barnes PJ: Inflammatory response to sputum induction measured by exhaled markers. Respiration 2005;72:594–599.
6.
Ratnawati , Morton J, Henry RL, Thomas PS: Exhaled breath condensate nitrite/nitrate and pH in relation to paediatric asthma control and exhaled nitric oxide. Pediatr Pulmonol, in press.
7.
O’Brien RJ, Drizd TA: Roentgenographic determination of total lung capacity: normal values from a National Population Survey. Am Rev Respir Dis 1983;128:949–952.
8.
Franklin PJ, Moeller A, Hall GL, Stick SM: Measuring total nitrite/nitrate in exhaled breath condensate: methodological issues (abstract). Am J Respir Crit Care Med 2003;167:A977.
9.
Chladkova J, Krcmova I, Chladek J, Cap P, Micuda S, Hanzalkova Y: Validation of nitrite and nitrate measurements in exhaled breath condensate. Respiration 2006;73:173–179.
10.
Davidsson A, Naidu Sjosward K, Lundman L, Schmekel B: Quantitative assessment and repeatability of chlorine in exhaled breath condensate. Respiration 2005;72:529–536.
11.
Kharitonov SA, Barnes PJ: Exhaled nitric oxide, carbon monoxide, and breath condensate; in Marczin N, Kharitonov SA, Yacoub MH, Barnes PJ (eds): Disease Markers in Exhaled Breath. New York, Marcel Dekker, 2003, vol 170, pp 199–218.
12.
Milledge JS: Respiratory water loss at altitude. Newslett Int Soc Mountain Med 1992;2:5–7.
13.
Ferrus L, Commenges D, Gire J, Varene P: Respiratory water loss as a function of ventilatory or environmental factors. Respir Physiol 1984;56:11–20.
© 2006 S. Karger AG, Basel
2006
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.